NCT05591092Leállítva
Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery
Radioiodine Scanning for Pre-Surgical Evaluation of Follicular Thyroid Nodules
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. aug. 11.
Megadott ok: Slow accrual
Rövid összefoglaló (regiszter, angolul)
This study evaluates radioiodine planar and SPECT/CT imaging with iodine-123 in patients with follicular thyroid nodules prior to surgery. Because biopsy alone is not sufficient to distinguish between malignant follicular thyroid nodules and benign follicular thyroid nodules, patients with follicular thyroid lesions are referred for surgery for further evaluation. A non-invasive imaging method that can accurately determine malignancy in follicular thyroid nodules would be valuable in patient management and could potentially spare patients unnecessary surgery. Planar imagine uses a gamma camera to obtain 2D images and SPECT/CT imaging is a special type of CT scan in which a small amount of a radioactive drug is injected into a vein and a scanner is used to make detailed images of areas inside the body where the radioactive material is taken up by the tumor cells. Radioiodine planar and SPECT/CT imaging may be more accurate in distinguishing between benign follicular thyroid nodules and malignant follicular thyroid nodules to help reduce the need for surgery.
- Állapot (regiszter)
- Leállítva
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 2 (tényleges)
- Első benyújtás
- 2022. okt. 18.
- Kezdés
- 2023. nov. 10.
- Elsődleges befejezés
- 2025. jan. 21.
- Fő szponzor
- Mayo Clinic
- Betegségek
- Pajzsmirigyrák
- NCT-szám
- NCT05591092
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- Current use of anti-thyroid medications (methimazole or propylthiouracyl)
Más betegség
- Recent iodinated contrast, including intravenous (IV) and oral CT contrast or interventional vascular or cardiac study (within 6 weeks)
Egyéb
- Hurthle cell adenoma
- Current thyroid hormone supplementation
- Less than 2 days after thyroid nodule FNA/biopsy
- Presence of another nodule of similar size in the same area of thyroid lobe, which could impair localization of the nodule on SPECT/CT images
- Less than 2/3 of normal thyroid tissue present in either thyroid lobe without nodules
- Positive pregnancy test
- All women who are breastfeeding
Kiket keres a vizsgálat
- Age \> 18 years
- Any gender
- Patients will have had no therapy for their thyroid nodule prior to enrollment
- Negative urine pregnancy test within 48 hours before the administration of radiopharmaceutical in women of childbearing potential
- Follicular neoplasm or suspicious of follicular neoplasm, cytopathology on biopsy of thyroid nodule
- Any outside fine needle aspiration (FNA) reports are to be reviewed by a Mayo pathologist
- Nodules 1-4 cm with solid appearance on ultrasound
- Ultrasound images and report documented in medical record, including the size of the nodule and location (upper, mid or lower portion of the thyroid lobe)
- At least 2/3 of either thyroid lobe without nodules should be present to allow for the measurement of uptake in unaffected thyroid tissue
- Thyroid stimulating hormone (TSH) 0.3-3.0 mIU/L
- Patient is scheduled or being considered for surgical resection of the nodule
- I-123 planar and Single Photon Emission Computed Tomography (SPECT)/Computed Tomography (CT) can be scheduled at least 2 days after biopsy and before surgery
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Egyesült Államok | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.